TOKYO, Mar 19 (Pulse News Wire) – Chiome Bioscience Inc. (4583.T) reported the massive exercise of its 23rd warrant options (exercise price adjustment clause attached) during the period from March 1, March 19, 2026 through March 18, March 01, 2026.
According to the report, a total of 1,461,300 warrants were exercised during this period, representing 10.74% of the total issuance. As of the end of February, there were 107,738 outstanding unexercised warrants corresponding to 10,773,800 shares.
At the current point, the number of outstanding unexercised warrants stands at 93,125. Exercise details for the month are as follows: | Exercise Date | Transferred Treasury Shares | Number of Exercised Warrants | Issued New Shares | Exercise Price (JPY) | |--------------|---------------------------|----------------------------|------------------|--------------------| | Mar 2 | - | - | - | 105.8 | | Mar 4 | - | - | 2,000 | 95.7 | | Mar 5 | - | 200,000 | - | 95.7 | | Mar 6 | - | - | - | 95.7 | | Mar 9 | - | - | - | 95.7 | | Mar 10 | - | 420,900 | 4,209 | 97.6 | | Mar 11 | 200,000 | - | 2,000 | 100.3 | | Mar 12 | - | - | - | 100.3 | | Mar 13 | - | - | - | 100.3 | | Mar 16 | - | 140,400 | 1,404 | 98.5 | | Mar 17 | 100,000 | - | 1,000 | 97.6 | | Mar 18 | - | 400,000 | 4,000 | 97.6 | At the end of February, the total number of ordinary shares issued was 70,890,000, including treasury shares of 12,229.
🟡 Confidence: Standard AI-translated content.